Total Payments
$19,785
2023 Payments
$895.58
Companies
19
Transactions
752
Medicare Patients
333
Medicare Billing
$24,177
Payment Breakdown by Category
Food & Beverage$13,601 (68.7%)
Other$4,771 (24.1%)
Travel$1,139 (5.8%)
Education$273.76 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,601 | 736 | 68.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,771 | 4 | 24.1% |
| Travel and Lodging | $1,139 | 4 | 5.8% |
| Education | $273.76 | 8 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $10,127 | 197 | $0 (2023) |
| ViiV Healthcare Company | $3,901 | 230 | $0 (2023) |
| Janssen Biotech, Inc. | $2,001 | 142 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,131 | 51 | $0 (2023) |
| Theratechnologies Inc. | $859.32 | 38 | $0 (2023) |
| AbbVie Inc. | $548.53 | 25 | $0 (2023) |
| EMD Serono, Inc. | $477.83 | 36 | $0 (2022) |
| Janssen Products, LP | $227.99 | 3 | $0 (2021) |
| Napo Pharmaceuticals Inc | $195.31 | 11 | $0 (2023) |
| Mylan Pharmaceuticals Inc. | $70.56 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $895.58 | 39 | ViiV Healthcare Company ($385.63) |
| 2022 | $1,693 | 78 | ViiV Healthcare Company ($601.67) |
| 2021 | $2,366 | 104 | ViiV Healthcare Company ($779.23) |
| 2020 | $1,519 | 78 | ViiV Healthcare Company ($474.77) |
| 2019 | $2,259 | 139 | Gilead Sciences, Inc. ($740.70) |
| 2018 | $2,714 | 155 | Gilead Sciences, Inc. ($718.32) |
| 2017 | $8,337 | 159 | Gilead Sciences Inc ($6,881) |
All Payment Transactions
752 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: VIROLOGY | ||||||
| 06/13/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: VIROLOGY | ||||||
| 04/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.47 | General |
| 04/12/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: HIV | ||||||
| 04/12/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: HIV | ||||||
| 04/05/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 04/04/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: HIV | ||||||
| 04/04/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: VIROLOGY | ||||||
| 03/30/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.01 | General |
| 03/29/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: HIV | ||||||
| 03/28/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: HIV | ||||||
| 03/21/2023 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: HIV | ||||||
| 03/20/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.65 | General |
| 03/17/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $113.85 | General |
| Category: HIV | ||||||
| 03/15/2023 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| Category: Infectious Disease | ||||||
| 03/15/2023 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| Category: Infectious Disease | ||||||
| 03/14/2023 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $23.30 | General |
| Category: Infectious Disease | ||||||
| 03/14/2023 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $23.30 | General |
| Category: Infectious Disease | ||||||
| 03/09/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.18 | General |
| 03/08/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: HIV | ||||||
| 03/01/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: HIV | ||||||
| 03/01/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/28/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: HIV | ||||||
| 02/24/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.94 | General |
| 02/21/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 26 | 27 | $3,536 | $549.99 |
| 2022 | 3 | 68 | 106 | $16,310 | $4,987 |
| 2021 | 4 | 108 | 208 | $19,478 | $10,351 |
| 2020 | 4 | 131 | 209 | $19,135 | $8,289 |
Total Patients
333
Total Services
550
Medicare Billing
$24,177
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $3,256 | $432.39 | 13.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 14 | $280.00 | $117.60 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 54 | $12,552 | $4,070 | 32.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 24 | $3,278 | $833.82 | 25.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 28 | $480.00 | $83.01 | 17.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 82 | $12,300 | $6,864 | 55.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 44 | $4,400 | $2,533 | 57.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 22 | $2,178 | $773.42 | 35.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 29 | 60 | $600.00 | $180.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 62 | $9,300 | $3,133 | 33.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 60 | $6,000 | $3,111 | 51.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 32 | 49 | $3,455 | $1,931 | 55.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 22 | 38 | $380.00 | $113.34 | 29.8% |
About Dr. William Robbins, M.D
Dr. William Robbins, M.D is a Infectious Disease healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831110535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Robbins, M.D has received a total of $19,785 in payments from pharmaceutical and medical device companies, with $895.58 received in 2023. These payments were reported across 752 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($13,601).
As a Medicare-enrolled provider, Robbins has provided services to 333 Medicare beneficiaries, totaling 550 services with total Medicare billing of $24,177. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease, Specialist
- Location Orlando, FL
- Active Since 07/21/2006
- Last Updated 11/29/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831110535
Products in Payments
- Genvoya (Drug) $4,239
- DOVATO (Drug) $1,858
- SYMTUZA (Drug) $907.64
- PREZCOBIX (Drug) $881.10
- CABENUVA (Biological) $725.16
- TRIUMEQ (Drug) $653.27
- EGRIFTA (Drug) $549.26
- ISENTRESS (Drug) $493.73
- JULUCA (Drug) $481.75
- Symtuza (Drug) $472.52
- SEROSTIM (Biological) $340.10
- TROGARZO (Drug) $310.06
- MAVYRET (Drug) $309.15
- PIFELTRO (Drug) $252.09
- ZERBAXA (Drug) $248.36
- Mavyret (Drug) $239.38
- Biktarvy (Drug) $239.27
- Mytesi (Drug) $195.31
- DIFICID (Drug) $124.03
- Serostim (Biological) $57.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Orlando
Dr. Charlotte-Paige Rolle, M.d, M.D
Infectious Disease — Payments: $520,539
Infectious Disease $520,539
Federico Hinestrosa, Md, MD
Infectious Disease — Payments: $331,463
Infectious Disease $331,463
Vincent Hsu, Md, MD
Infectious Disease — Payments: $199,883
Infectious Disease $199,883
Edwin Dejesus, Md, MD
Infectious Disease — Payments: $132,951
Infectious Disease $132,951
Patricia Couto, M.d, M.D
Infectious Disease — Payments: $22,106
Infectious Disease $22,106
Dr. Jose Giron, M.d, M.D
Infectious Disease — Payments: $16,474
Infectious Disease $16,474